CaseTrail

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.

139 S. Ct. 628 · Decided January 22, 2019 · Supreme Court of the United States

Record summary. This page is generated from the Supreme Court Database’s coded data about the case. It describes who decided what, not the Court’s reasoning. Read the opinion itself before relying on it. Not legal advice.

At a glance

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc. was decided on January 22, 2019 unanimously (9–0). The Court affirmed the lower court's decision. Justice Clarence Thomas wrote the opinion of the Court. SCDB classifies its main issue as “Patents” in the Economic Activity area.

Read the opinion

Case details

Citations
139 S. Ct. 628 · 202 L. Ed. 2d 551 · 2019 U.S. LEXIS 807
Docket number
17-1229
Decided
January 22, 2019
Argued
December 4, 2018
Court era
Roberts Court
Decision type
Opinion of the Court (orally argued)
Disposition
Affirmed
Outcome for petitioner
The petitioning party did not receive a favorable disposition
Vote
9–0 (unanimous)
Majority opinion
Clarence Thomas
Opinion assigned by
John G. Roberts Jr.
How the case arrived
Certiorari
Issue (SCDB)
Patents
Legal provision
35 USC 102
Type of law
Infrequently litigated statute
Decision direction (SCDB)
Liberal what this means

How the Justices voted

Full case caption

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.

SCDB identifiers: case 2018-035, docket 2018-035-01.

Other cases on “Patents”

See all

Same Term, same area (Economic Activity)

See all

Source: Supreme Court Database, 2026 Release 01 (data file dated September 8, 2026). Imported into CaseTrail November 5, 2026. Coverage: decisions from the 1946 through 2025 Terms. Methodology · Report an error